SG Americas Securities »

Ptc Therapeutics shares owned by SG Americas Securities

Quarter-by-quarter ownership of Ptc Therapeutics shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Ptc Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $20M 150k 132.78

More positions owned by SG Americas Securities

Broadcom (AVGO)
Alphabet Inc Class A cs (GOOGL)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Facebook Inc cl a (META)
Alphabet Inc Class C cs (GOOG)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf (SPY)
Linde (LIN)
Johnson & Johnson (JNJ)
Equinix (EQIX)
Costco Wholesale Corporation (COST)
Lumentum Hldgs Opt Call Option
Pinduoduo (PDD)

View all positions for SG Americas Securities

Top funds holding Ptc Therapeutics

Franklin Resources
Tenor Capital Management
Capstone Investment Advisors
OZ Management
Linden Advisors
DeepCurrents Investment Group
Lazard Asset Management
Whitebox Advisors
BlackRock
SSI Investment Management
Lord, Abbett & Co
FMR
CSS
Central Pacific Bank - Trust Division
SG Americas Securities

View all funds holding Ptc Therapeutics